Clinical trials look at new ways to prevent, detect, or treat disease. They are a part of clinical research and at the heart of almost all medical advances. The goal of clinical trials is to determine if a new test or treatment is effective and safe. The MagForce® Clinical Study is being conducted to determine if the NanoTherm™ Thermal Ablation Therapy is safe and effective in the treatment of certain patients’ prostate cancer.

People participate in clinical trials for a number of different reasons. Some people participate to help others in that the hope they are helping to contribute to the advancement of science. Some people participate in the hope of receiving a benefit from the experimental treatment for their illness or disease. Others participate in order get additional care and attention from the clinical staff conducting the trial. Finally, some may participate for the financial benefit or other type of compensation that may be available.

Prior to participating in the clinical study, all potential subjects will have a meeting with one of the study’s principal investigators. This initial meeting will help you learn more about the clinical trial and help answer any questions you may have. Prior to enrolling in the study, you will be asked to review and sign an “Informed Consent” which provides extensive detailed information related to the risks and benefits of participation as well as the details of each step of the study. The principal investigator will be available to answer any questions that you might have about all known and potential risks. At any point during this process of learning about the study, you may opt to proceed with treatment by your physician.